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Abstract
Introduction
Nearly half of HIV-positive patients experience mental health and substance use problems,
but many do not receive adequate or ongoing mental health or addiction care. This lack of
ongoing care can result in the use of costly acute care services. Prospective evaluations of
the relationship between psychiatric and substance use disorders and acute care services
use are lacking, and this information is needed to understand unmet needs and improve
access to appropriate services.
Methods
We conducted a secondary data analysis from a multicenter, longitudinal, prospective
cohort study (n = 3,482 adults) between October 1, 2007 and March 31, 2013. We used
explanatory extended Cox proportional hazard regression models to examine the impact of
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current depression and recreational drug use on acute care services use, and to explore
whether current depression and recreational drug use were associated with potentially
avoidable acute care services use.
Results
Over our 5.5 year study period, HIV-positive participants with current depression-only (aHR
[95% CI]:1.2[1.1–1.4]), recreational drug use-only (1.3[1.1–1.6]), or co-occurring depression
and recreational drug use (1.4[1.2–1.7]) were associated with elevated hazard of emer-
gency department (ED) encounters compared to participants without these conditions. Over
half of ED encounters were potentially avoidable. Participants with current depression-only
(1.3[1.1–1.5];1.3[1.03–1.6]), recreational drug use-only (1.3[1.04–1.6];1.5[1.1–1.9]), or co-
occurring depression and recreational drug use (1.3[1.04–1.7];1.4[1.06–1.9]) were associ-
ated with elevated hazard of low-acuity or repeated ED encounters respectively.
Conclusions
We found a significant increase in ED services use and potentially avoidable ED encounters
(including low-acuity or repeated ED encounters), particularly among those with either cur-
rent depression or recreational drug use. These findings emphasize the challenges in man-
aging HIV and mental health/addiction co-morbidities in the current HIV care model. Future
research should evaluate integrated and collaborative care programs for improving the coor-
dination of care and effectively treat mental health and addiction problems among HIV-posi-
tive patients in Ontario.
Introduction
Nearly half of people living with HIV experience mental health and substance use problems
[1–3]. However, many of these individuals, particularly those who are the most socially disad-
vantaged, do not receive adequate mental health or addiction care and support [4–7]. Subopti-
mal mental health and addiction treatment for those with HIV increases the probability of
non-adherence to combination antiretroviral therapy (cART), and the risk of poorer clinical
outcomes and co-morbidity and mortality. Suboptimal mental health and addiction care may
also result in the increased use of costly acute care services, such as emergency department
(ED) encounters and hospital admissions [4, 8–12].
A large body of literature has described the impacts of mental health and substance use-
related problems on acute care services use among patients with multi-morbidities [13, 14].
For example, in a recent meta-analysis, Dickens et al. (2012) found that patients with chronic
health conditions and depression had a 49% higher likelihood of using inpatient services com-
pared to patients without depression [14]. A recent scoping review also demonstrated that
mental health disorders and substance use problems are important factors for frequent emer-
gency department use and the unscheduled use of health services among patients with long-
term chronic conditions [13].
Similar patterns of acute care use have been observed among people living with HIV. In the
last several decades, the overall rate of hospitalization among people living with HIV on com-
bination antiretroviral therapy has declined, but their rate of hospital admissions for concomi-
tant psychiatric disorders and substance use has increased [9, 12, 15]. Two U.S. studies found
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that hospitalization for psychiatric disorders among people living with HIV increased by 42–
73% from the mid-1990s to the early 2000s [9, 12]. A recent meta-analysis of 85 cohort studies
(with data published after 2007) reported that psychiatric disorders were one of the most com-
mon non-AIDS-related diagnoses for hospital admissions in Europe among those with HIV,
based solely on pooled proportions of key diagnoses in hospital admissions [15]. With respect
to ED encounters, Josephs et al. (2010) found that HIV-positive illicit drug users (current or
former) in the United States had a 59–85% higher rate of ED encounters compared to those
who never used drugs [10]. In another recent U.S. study of people living with HIV who pre-
sented to the ED, those with mental health and substance use problems had a higher rate of
subsequent hospital admissions, admissions to other facilities, or discharge against medical
advice [8].
However, very few studies have assessed the prospective relationship between co-occurring
psychiatric and substance use disorders and acute care services use among people living with
HIV. Most of the current studies have been limited by cross-sectional or ecological designs, or
by self-reported acute care services use. Additionally, most studies have been from the United
States or Europe. The sole Canadian study was limited to injection drug users and focused on
general ED encounters only. This latter study also controlled for only a limited number of
social demographics, and did not consider co-existing psychiatric disorders [11].
Given these limitations, the primary goal of our study was to determine the relationship of
current depression and recreational drug use on acute care. Our second goal was to determine
how current depression and recreational drug use were associated with potentially avoidable
acute care use. Understanding these relationships is critical in resource-constrained health
care systems for planning and designing cost-effective preventive and responsive mental health
care programs for people living with HIV.
Materials and methods
Study design
We analysed data collected between October 1, 2007 and March 31, 2013 using linked data
from the population-based administrative health databases held at the Institute for Clinical
Evaluative Sciences (ICES) and the Ontario HIV Treatment Network Cohort Study (OCS).
The study was approved by the HIV research ethics board of the University of Toronto and
the institutional review boards at Sunnybrook Health Sciences Centre and participating HIV
clinics across Ontario (Ottawa Health Science Network Research Ethics Board, University of
Western Ontario Research Ethics Board, St. Michael’s Hospital Research Ethics Board, the
Research Ethics Board of Health Sciences North, Sunnybrook Health Sciences Centre Research
Ethics Board, University Health Network Research Ethics Board, and Windsor Regional Hos-
pital Research Ethics Board).
Data sources
The OCS is a longitudinal and multicentre prospective cohort of HIV-positive participants,
and contains a wide range of socio-demographic information, psychosocial and behavioural
data, and medical and clinical data. A full description of the OCS cohort has been published
elsewhere [16]. ICES holds a comprehensive collection of administrative claims and billing
data in the province of Ontario. These two de-identified databases were linked at the individ-
ual level using encrypted health care numbers as unique identifiers and were made available
through a data sharing agreement with the Ontario Ministry of Health and Long Term Care.
Databases used for this study and held by ICES were: the Ontario Health Insurance Plan
(OHIP) database, the Canadian Institute for Health Information discharge abstract database
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(DAD), the National Ambulatory Care Reporting System (NACRS), and the Registered Per-
sons Database (RPDB).
These databases contain all medical and hospital services covered by OHIP (a province-
wide publicly-funded insurance plan) for all residents of Ontario. The OHIP claims database
captures most physician claim billings in the province. NACRS contains all ED encounters
and information regarding their triage level, diagnosis at discharge, and visit disposition at dis-
charge from the ED [17]. DAD contains abstracts of all discharges from acute, chronic, and
rehabilitation inpatient facilities [18]. The RPDB, which contains Ontario vital statistics data,
was used to obtain OCS participants’ dates of death [19]. Details about the linked data source
have been provided in recent studies [5, 20].
Study population
OCS participants were included if they were eligible for OHIP and had completed their first
standard OCS questionnaire on or prior to March 31, 2012, allowing for at least one year to
observe acute care services use events. The date of completion of the first questionnaire served
as the baseline date. We excluded 13 OCS participants who had missing measures on current
depression and recreational drug use at the baseline visit. We further excluded 206 OCS partic-
ipants who had at least one ED encounter or hospital admission 30 days prior to baseline to
ensure that the participants were not re-admitted for a problem that was identified prior to
baseline. We included 3,482 OCS participants in our final analyses. The median number of
days between interviews was 372 (interquartile range: 339, 452 days). The median length of fol-
low-up was 2.8 years (interquartile range: 1.2, 3.6 years). The median number of interviews
completed was 3 (interquartile range: 2, 4).
Main Exposure: Current depression and recreational drug use
The Center for Epidemiologic Studies Depression (CES-D20) scale with a cut point of 23 (Sen-
sitivity [SE]: 1.0; Specificity [SP]: 0.87) or the Kessler Psychological Distress Scale (K10) scale
with a cut point of 22 (SE: 0.97, SP: 0.81) was used to identify “current depression” during the
past four weeks. Current depression and recreational drug use status were measured at base-
line and at each follow-up interview during the five-year study period. As described in recent
articles, due to resource-constraints at several participating HIV clinics, K10 was administered
to 61% of OCS participants and the CES-D20 was administered to the rest [5, 20]. The excellent
reliability and diagnostic accuracy of these two screening instruments have been validated in a
sample of OCS participants when compared to the Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for major depression [21]. Addi-
tionally, the CES-D20 and K10 demonstrate good inter-rater agreement (Cohen’s Kappa Statis-
tic = 0.79) when compared to the DSM-IV-TR criteria for a diagnosis of major depression
[21].
In the interview, OCS participants were asked whether they had used any of the following
drugs for recreational or other non-medical purposes over the past six months: anabolic ste-
roids, amphetamines, methamphetamines, cocaine, crack/freebase, club drugs, heroin, opiates,
tranquilizers, or other substances. We did not include alcohol use as a measure of recreational
drug use because our linked dataset does not have a reliable measure for this condition.
We then categorized our main exposure variable into four groups: (1) those with current
depression only; (2) those with recreational drug use only; (3) those with co-occurring current
depression and recreational drug use; and (4) those without either current depression or recre-
ational drug use. This variable was updated at each OCS interview.
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Primary and secondary outcomes: ED encounters, hospital admissions, and
potentially avoidable ED encounters
Our primary outcomes were the index ED encounters and hospital admissions during our
study period. We included hospital admissions with at least one overnight stay. We excluded
visits related to delivery of a baby and its complications (International Classification of Dis-
eases, 10th Revision).
Among OCS participants who had at least one ED encounter, we further examined three
types of potentially avoidable ED encounters as secondary outcomes.
1. ED encounters with low-acuity were identified using level four or five of the five-level Cana-
dian triage and acuity scale (1 = resuscitation, 2 = emergency, 3 = urgent, 4 = semi-urgent,
5 = non-urgent) AND a visit disposition at discharge that indicated the participant was not
transferred to inpatient care [22].
2. Repeated ED encounters were defined by the discharge date of an ED encounter that
occurred 30 days following the index encounter at the same or a different facility [23].
3. ED encounters without seeking ambulatory care were defined as an ED encounter without
the participant having sought ambulatory care 30 days prior to the index encounter [24].
Covariates
We attempted to control for the effects of covariates that may be associated with current
depression and recreational drug use that might be associated with the use of acute care ser-
vices among OCS participants. These covariates included “need,” “predisposing,” and
“enabling” factors as defined in Andersen et al.’s socio-behavioural theoretical framework for
health services use [25].
Need factors are OCS participants’ perceived and evaluated health status. For the purposes
of our study, they included: the use of antidepressants (identified by the OCS participants’
medical records); CD4 cell counts of less than 200 μL (yes/no; based on HIV antigen test rec-
ords during the past six months); non-suppressed viral loads (>50 μL) (yes/no; based on HIV
viral load records during the past six months); number of years since HIV diagnosis; current
smoking (yes/no); physical health-related quality of life (based on the 12-Item Short Form Sur-
vey, 2nd version); current combination antiretroviral therapy use (yes/no; based on OCS par-
ticipants’ medical records); and physical multi-morbidity based on the Charlson-Deyo multi-
morbidity index of 17 ICD physical disease categories. We also included history of depression
(OHIP-ICD: 296 or 311), history of drug addiction/dependence (OHIP-ICD: 304), and history
of alcoholism (OHIP-ICD: 303), which were determined by whether the OCS participants had
a relevant diagnostic code in the OHIP database from the earliest available records in these
databases to a year before baseline (allowing a year as a washout period to avoid overlap of cur-
rent and past depression and substance use diagnosis).
Predisposing factors are characteristics that may predispose a person to seek care. We
included the following predisposing factors: age (grouped as 16–29, 30–39, 40–49, and50
years); self-reported gender (female vs. male); sexual orientation (self-reported as lesbian, gay,
bisexual or heterosexual); relationship status (married or living with a partner; or single, sepa-
rated, divorced, or widowed); self-reported ethnicity (grouped as Aboriginal, African/Carib-
bean/Asian/Latin American, or European decent); immigration status (grouped as Canadian
immigrant or Canadian born); current employment status (categorized as employed, unem-
ployed, student/retired, or recipient of Ontario Disability Support Program [ODSP]), and edu-
cational attainment (completed high school or less vs. more than high school education).
Impact of depression and recreational drug use on acute care service use among HIV-positive patients
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Enabling factors are resource-related characteristics that may enable OCS participants to
seek care. We included the following enabling factors: annual household income levels before
taxes and benefits (grouped as<$20,000, $20,000–$39,999, $40,000–$49,999, or$50,000
CAD); perceived difficulty in affording housing-related expenses; and perception of housing
and neighbourhood conditions.
Each of these covariates (except for the Charlson-Deyo multi-morbidity index, history of
depression, history of alcoholism, and history of drug addiction/dependence) were time-vary-
ing and updated at each OCS interview.
Statistical analysis
All statistical analyses were two-sided, had an a priori statistical significance level of p<0.05,
and were performed using STATA MP v. 13.1 [26]. All analyses were conducted at an ICES
secured computing centre.
We estimated the incidence rates (per 100 person-years) of ED encounters and hospital
admissions during our 5.5-year study period of the whole cohort and by their depression and
recreational drug use status reported at the baseline. Among those who had at least one ED
admission, we further estimated the incidence rates of low-acuity and repeated ED admission
and ED admission without seeking ambulatory care.
We constructed two explanatory extended Cox proportional hazard regression models to
examine the association between time-varying current depression and recreational drug use
status and index (1) ED encounters, and (2) hospital admissions during the 5.5-year follow-up
period among OCS participants. There were 43 deaths in our study cohort during the five-year
period, and most occurred after the index ED encounters or hospital admissions. For this rea-
son, we censored the participants at their date of death.
Among those who had at least one ED encounter, we constructed three additional explana-
tory extended Cox proportional hazard regression models to examine the impact of time-vary-
ing current depression and recreational drug use status on the index: (1) low-acuity ED
encounters; (2) repeated ED encounters; and (3) ED encounters without seeking ambulatory
care 30 days prior to the index encounter.
When selecting covariates in each multivariable regression model, we adopted a method
similar to a recent study [20]. Briefly, we used backward selection method [27–29]. At each
step of the backward selection procedure, four p-value thresholds (p< 0.004211, p< 0.15, p<
0.1, or p< 0.2) were considered separately to determine whether a covariate should be retained
in the model. The p-value threshold was calculated by Akaike information criteria [AICs] or
Bayesian information criteria [BICs] of two nested models [27–29]. Additionally, in each back-
ward selection procedure, we forced covariates in the multivariable models based on a priori
evidence from the literature [8–12, 15]. We forced gender, perceived difficulty in affording
housing-related expenses, and current employment status in the multivariable models for ED
and potentially avoidable ED encounters. We forced age, CD4 cell counts of less than 200 μL,
non-suppressed viral loads, self-reported ethnicity, current employment status, multi-morbid-
ity index, and physical quality-of-life in multivariable models for hospital admissions, The
final set of covariates was selected based on the lowest AICs and BICs of the full model (includ-
ing all covariates) and the final models according to the four p-value criteria [27–29]. We fur-
ther examined the uncertainty of this model building procedure by generating 1,000
bootstrapped samples from the original dataset to examine the probability of each covariate
(without a priori evidence) included in the model [27–29].
For each final explanatory multivariable model, we controlled for differences between the
CES-D20 and K10 as well as the residual difference of OCS participants’ characteristics by clinic
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type [20]. In addition, we tested proportionality assumptions in each final model using
Schoenfeld residuals against time for each of the covariates and interactions with linear time
and natural log of time [27, 29]. When a covariate did not meet the proportionality assump-
tions, we included an interaction term between any covariate and natural log of time in each
final model.
Adjusted hazard ratios (aHRs) and 95% confidence intervals (CI) were reported.
Results
Over the 5.5-year study period, we included 3,482 OCS participants at baseline with a median
2.3 years of follow-up (95% CI: 2.2–2.5). The median age of OCS participants was 46 years
(ranging from 17 to 85 years), and 574 (16.5%) were female. Of the cohort, 696 (20.0%) were
identified as having current depression only, 396 (11.4%) with recreational drug use only, 253
(7.3%) with co-occurring current depression and recreational drug use, and 2,137 (61.4%)
with no current depression or recreational drug use (see Table 1).
Table 1. Baseline characteristics by current depression and recreational drug use status (N = 3,482).
Characteristics Current depression (CD) and recreational drug use (RDU) status
Without CD & RDU With CD-only With RDU-only Co-occurring CD & RDU
(N = 2137, 61.4%) (N = 696, 20.0%) (N = 396, 11.4%) (N = 253, 7.3%)
Demographic characteristics
Age
16–29 years 110 (5.1%) 42 (6.0%) 48 (12.1%) 22 (8.7%)
30–39 years 343 (16.1%) 143 (20.5%) 82 (20.7%) 67 (26.5%)
40–49 years 86 6(40.5%) 306 (44.0%) 178 (44.9%) 120 (47.4%)
 50 years 818 (38.3%) 205 (29.5%) 88 (22.2%) 44 (17.4%)
Gender
Female 349 (16.3%) 159 (22.8%) 28 (7.1%) 38 (15.0%)
Male 1787 (83.6%) 537 (77.2%) 368 (92.9%) 215 (85.0%)
Sexual orientation
Gay, lesbian, or bisexual 1420 (66.4%) 422 (60.6%) 333 (84.1%) 168 (66.4%)
Heterosexual 704 (32.9%) 270 (38.8%) 63 (15.9%) 83 (33.8%)
Marital status
Married / living with partner 945 (44.2%) 232 (33.3%) 144 (36.4%) 63 (24.9%)
Single, separated/divorced, or widowed 1189 (55.6%) 462 (66.4%) 251 (63.4%) 185 (73.1%)
Ethnicity
Aboriginal 177 (8.3%) 80 (11.5%) 38 (9.6%) 44 (17.4%)
African, Caribbean, Asian or Latin American 497 (23.3%) 176 (25.3%) 55 (13.9%) 29 (11.5%)
European decent 1457 (68.2%) 437 (62.8%) 301 (76.0%) 180 (71.1%)
Immigration status
Canadian immigrant 667 (31.2%) 232 (33.3%) 74 (18.7%) 43 (17.0%)
Canadian born 1465 (68.6%) 463 (66.5%) 321 (81.1%) 209 (82.6%)
Socio-economic Status
Employment status
Unemployed 166 (7.8%) 82 (11.8%) 41 (10.4%) 35 (13.8%)
Student/retired 241 (11.3%) 37 (5.3%) 23 (5.3%) 7 (2.8%)
Recipient of Ontario Disability Support Program 541 (25.3%) 380 (54.6%) 112 (28.3%) 143 (56.5%)
Employed 1185 (55.5%) 193 (27.7%) 219 (55.3%) 67 (26.5%)
Educational attainment
(Continued)
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Table 1. (Continued)
Characteristics Current depression (CD) and recreational drug use (RDU) status
Without CD & RDU With CD-only With RDU-only Co-occurring CD & RDU
(N = 2137, 61.4%) (N = 696, 20.0%) (N = 396, 11.4%) (N = 253, 7.3%)
Completed high school or less 627 (29.3%) 284 (40.8%) 100 (25.3%) 108 (42.7%)
Completed more than high school 1510 (70.7%) 412 (59.2%) 296 (74.7%) 145 (57.3%)
Annual household income (CAD) before withholding taxes/benefits
< $20,000 433 (20.3%) 263 (37.8%) 82 (20.7%) 111 (43.9%)
$20,000 to $39,999 371 (17.4%) 160 (23.0%) 72 (18.2%) 37 (14.6%)
$40,000 to $49,999 323 (15.1%) 63 (9.1%) 40 (10.1%) 20 (7.9%)
 $50,000 829 (38.8%) 136 (19.5%) 162 (40.9%) 51 (20.2%)
Housing and Neighbourhood Conditions
Difficulty in affording housing-related expenses a
Yes 376 (17.6%) 264 (37.9%) 71 (17.9%) 83 (32.8%)
No 1761 (82.4%) 432 (62.1%) 325 (82.1%) 170 (67.2%)
Worry about eviction b
Yes 235 (11.0%) 182 (26.1%) 45 (11.4%) 60 (23.7%)
No 1901 (89.0%) 514 (73.9%) 351 (88.6%) 193 (76.3%)
Control over housing situation b
Yes 1732 (81.0%) 438 (62.9%) 317 (80.1%) 164 (64.8%)
No 405 (19.0%) 258 (37.1%) 79 (19.9%) 89 (35.2%)
Sense of belonging to neighbourhood b
Yes 1533 (71.7%) 372 (53.4%) 273 (68.9%) 136 (53.8%)
No 604 (28.3%) 324 (46.6%) 123 (31.1%) 117 (46.2%)
Perceived good location of home b
Yes 1725 (80.7%) 450 (64.7%) 324 (81.8%) 164 (64.8%)
No 412 (19.3%) 246 (35.3%) 72 (18.2%) 89 (35.2%)
Health Status
History of depression c
Yes 673 (31.5%) 384 (55.2%) 153 (38.6%) 157 (62.1%)
No 1464 (68.5%) 312 (44.8%) 243 (61.4%) 96 (37.9%)
History of alcoholism d
Yes 152 (7.1%) 92 (13.2%) 65 (16.4%) 68 (26.9%)
No 1962 (91.8%) 596 (85.6%) 330 (83.3%) 184 (72.7%)
History of drug addiction/dependence e
Yes 308 (14.4%) 149 (21.4%) 126 (31.8%) 126 (49.8%)
No 1806 (84.5%) 539 (77.4%) 269 (67.9%) 126 (49.8%)
Current smoker
Yes 683 (32.0%) 325 (46.7%) 217 (54.8%) 176 (69.6%)
No 1450 (67.9%) 369 (53.0%) 177 (44.7%) 76 (30.0%)
Current use of combination antiretroviral Therapy
Yes 1865 (87.3%) 594 (85.3%) 313 (79.0%) 188 (74.3%)
No 272 (12.7%) 102 (14.7%) 83 (21.0%) 65 (25.7%)
Antidepressant use f
Yes 374 (17.5%) 284 (40.8%) 89 (22.5%) 108 (42.7%)
No 1763 (82.5%) 412 (59.2%) 307 (77.5%) 145 (57.3%)
Charlson physical multi-morbidity index 1
Yes 491 (23.0%) 206 (29.6%) 78 (19.7%) 80 (31.6%)
No 1646 (77.0%) 490 (70.4%) 318 (80.3%) 173 (68.4%)
(Continued)
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Table 1 depicts the baseline characteristics by current depression and recreational drug use
status. When compared to OCS participants with neither current depression nor recreational
drug use, those with co-occurring conditions were more likely to be younger (<50 years) and
more likely to be Canadian born. In addition, OCS participants with co-occurring conditions
were more likely to live in vulnerable situations. For example, they were more likely to be
unemployed or receiving ODSP, have basic education only, have a low household income, and
feel dissatisfied with their home or neighborhood. OCS participants with co-occurring condi-
tions were also more likely to have a history of multi-morbidity, depression, alcoholism, and
drug addiction, and were more likely to be current tobacco users. They were also more likely
to have detectable viral loads and less likely to be currently taking cART.
Similar patterns of characteristics were found among OCS participants in the current
depression-only subgroup. However, these participants were more likely to be female and het-
erosexual compared to participants without current depression or recreational drug use.
For the recreational drug use-only subgroup, participants were more likely to be male, and
gay or bisexual. However, we did not find any statistically significant differences among these
participants in terms of employment status, annual household incomes, histories of multi-
Table 1. (Continued)
Characteristics Current depression (CD) and recreational drug use (RDU) status
Without CD & RDU With CD-only With RDU-only Co-occurring CD & RDU
(N = 2137, 61.4%) (N = 696, 20.0%) (N = 396, 11.4%) (N = 253, 7.3%)
Recent CD4 cell count (<200 μL)
Yes 190 (8.9%) 70 (10.1%) 44 (11.1%) 43 (17.0%)
No 1944 (91.0%) 625 (89.8%) 352 (88.9%) 209 (82.6%)
Detectable recent viral load (>50 μL)
Yes 493 (23.1%) 191 (27.4%) 138 (34.8%) 126 (49.8%)
No 1644 (76.9%) 505 (72.6%) 258 (65.2%) 127 (50.2%)
Years since HIV diagnosis, median (25th to 75th percentile) 11.7 (5.8–17.7) 12.0 (5.4–16.8) 8.8 (3.4–15.7) 7.7 (3.2–14.8)
Physical quality-of-life (SF12v2), median (25th to 75th percentile) 53.2 (45.4–56.7) 46.0 (36.4–55.2) 54.8 (47.8–7.8) 46.2 (37.5–56.8)
Instrument Type g
CES-D20 897 (42.0%) 242 (34.8%) 148 (37.4%) 54 (21.3%)
K10 1240 (58.0%) 454 (65.2%) 248 (62.6%) 199 (78.7%)
 The reference group is OCS participants without current depression and/or recreational drug use.
a Difficulty in affording house-related expenses was defined as a patient’s self-reported “Very difficult” or “Fairly difficult” to the following question: “Considering your
household income, how difficult is it for you to meet your monthly housing-related costs?(Housing costs include rent/mortgage, property taxes and utilities only).”
b A 5-point Likert scale (strongly agree to strongly disagree) was used. We dichotomized their response into “yes” (strongly agree/agree) and “no” (neutral/disagree/
strongly disagree).
c History of depression was defined as having a past depression-related diagnosis in OHIP records (OHIP ICD-9: 296 and 311), from the earliest available records to a
year before baseline.
d History of alcoholism was defined as a diagnostic code of alcohol dependence/abuse in OHIP (ICD-9: 303) from the earliest available records to a year before baseline.
e History of drug addiction/dependence was defined as a diagnostic code of drug dependence/addiction in OHIP (ICD-9: 304) from the earliest available records to a
year before baseline.
f The definition of antidepressants was based on the first line of antidepressants for managing depression in adults recommended by the Canadian Network for Mood
and Anxiety Treatments (CANMAT) Clinical guidelines (Lam et al., 2009).
g There are two instruments for identifying current depression administered by clinic nurses and assistants during the participant’s regular clinical appointments. Due
to constraints on human resources and time in several HIV clinics, 61% of HIV-positive participants were administered the 10-item Kessler Psychological Distress Scale
(K10) and 39% were administrated the 20-item Centre for Epidemiologic Studies Depression Scale (CES-D20). Full details of the cohort can be found on the study
website: http://www.ohtncohortstudy.ca/
https://doi.org/10.1371/journal.pone.0195185.t001
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morbidity, or housing satisfaction compared to OCS participants with neither current depres-
sion nor recreational drug use.
Crude incidence rate of acute care services use
Over the 5.5-year study period, of the 3,482 participants, there were 25.6 per 100-years (95%
CI: 24.5–26.8) and 6.9 per 100 person-years (95% CI: 6.4–7.4) incidence of ED encounters and
hospital admissions respectively. The current depression and recreational drug use status were
based on the baseline line measure. OCS participants with either current depression or recrea-
tional drug use had about a 1.3–2.2 fold higher incidence of ED encounters and hospital
admissions compared to those without these exposures (Table 2). We did not find that OCS
Table 2. Crude incidence rate (IR) per 100 person-years, crude hazard ratio (HR), and 95% confidence intervals (CI) for emergency department (ED) encounters,
hospital admissions, and potentially avoidable ED encounters, whole cohort and by current depression and recreational drug use status measured at the baseline.
ED encounters Hospital admissions Potentially avoidable ED encounters
(N = 2,108)
(N = 3,482) (N = 3,482) Low-acuity ED
encounters a
Repeated ED
encounters b
ED encounters
without seeking
ambulatory care c
IR Crude HR
Ratio
IR Crude HR
Ratio
IR Crude HR
Ratio
IR Crude HR
Ratio
IR Crude HR
Ratio
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95%
CI)
(95% CI)
Cohort 25.6 6.9 19.4 10.9 7.9
(24.5,
26.8)
(6.4, 7.4) (18.3,
20.6)
(10.2,
11.7)
(7.2,
8.6)
Current depression and recreational
drug use
Current depression-only 34.8 1.6 9.1 1.5 21.8 1.2 12.2 1.3 7.3 1.03
(31.8,
38.0)
(1.4, 1.7) (7.9,
10.4)
(1.3, 1.8) (19.4,
24.6)
(1.1, 1.4) (10.5,
14.1)
(1.1, 1.5) (6.5,
8.2)
(0.8, 1.3)
Recreational drug use-only 30.0 1.3 6.0 1.0 22.8 1.3 13.2 1.4 7.5 1.5
(26.4,
34.1)
(1.2, 1.5) (4.8, 7.6) (0.8, 1.3) (19.2,
27.0)
(1.1, 1.6) (10.8,
16.2)
(1.1, 1.8) (6.3,
9.0)
(1.2, 1.9)
Co-occurring current depressive
symptoms and recreational drug use
51.9 2.2 13.0 2.2 25.6 1.4 16.9 1.8 10.8 1.2
(44.8,
60.1)
(1.9, 2.6) (10.4,
16.1)
(1.7, 2.7) (21.1,
31.1)
(1.1, 1.7) (13.5,
21.1)
(1.4, 2.3) (8.7,
13.4)
(0.9, 1.7)
Without current depression and
recreational drug use (reference)
21.2 1 5.9 1 17.2 1 9.4 1 9.2 1
(20.0,
22.4)
(5.4, 6.5) (15.8,
18.6)
(8.5,
10.3)
(6.9,
12.2)
IR = Incidence rate
HR = Hazard ratio
CI = Confidence intervals
ED = Emergency department encounters
a Low-acuity ED encounters were identified using level four or five of the five-level Canadian triage and acuity scale (1 = resuscitation, 2 = emergency, 3 = urgent,
4 = semi-urgent, 5 = non-urgent) AND a visit disposition at discharge that indicated the participants were not transferred to inpatient care.
b Repeated ED encounters were defined by discharge date of an emergency department encounter that occurred within 30 days of a previous encounter at the same or a
different facility.
c Emergency department encounters without seeking ambulatory care were defined as emergency department encounters without an ambulatory visit to a physician in
the 30 days prior to the index encounter
https://doi.org/10.1371/journal.pone.0195185.t002
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participants in the recreational drug use-only subgroup had a higher incidence of hospital
admissions compared to those without either current depression or recreational drug use.
Among the 2,108 OCS participants with at least one ED encounter, there were 19.4 per
100-years (95% CI: 18.3–20.6), 10.9 per 100 person-years (95% CI: 10.2–11.7), and 7.9 per 100
person-years (95% CI: 7.2–8.6) incidence of low-acuity ED encounters, repeated ED encoun-
ters, and ED encounters without seeking ambulatory care, respectively. Based on the current
depression and recreational drug use status at the baseline, OCS participants with either cur-
rent depression or recreational drug use had about a 1.2–1.8 fold higher incidence of low-acu-
ity ED encounters or repeated ED encounters compared to those without either current
depression or recreational drug use. In addition, OCS participants in the recreational drug
use-only subgroup had a 1.5 fold higher incidence of having an ED encounter without having
sought ambulatory care 30 days prior to the index encounter (compared to those with neither
current depression nor recreational drug use problems).
Independent associations between current depression and/or recreational
drug use main exposures on acute care services use
Table 3 demonstrates the multivariable associations between participant characteristics and
ED encounters and hospital admissions. After adjustment, compared to OCS participants with
neither current depression nor recreational drug use, those with current depression only
(aHR: 1.2; 95% CI: 1.1–1.4), recreational drug use only (aHR: 1.3; 95% CI: 1.1–1.6), or co-
occurring conditions (aHR: 1.4; 95% CI: 1.2–1.7) were associated with elevated hazard of ED
encounters. For hospital admission, after adjustment, OCS participants with current depres-
sion-only (aHR: 1.2; 95% CI: 1.1–1.5) or co-occurring conditions (aHR: 1.6; 95% CI: 1.2–2.1)
were associated with elevated hazard of hospital admissions compared to OCS participants
without these conditions.
Table 3. Crude and adjusted hazard ratio (aHR) with 95% confidence intervals (CI) for associations between depression and recreational drug use exposure and
two acute care services use outcomes (N = 3,482).
Main Exposure Emergency Department Encounters Hospital Admissions
Crude HR aHR Crude HR aHR
(95% CI) (95% CI) (95% CI) (95% CI)
Depression-onlya 1.6 1.2 1.5 1.3
(1.4, 1.7) (1.06, 1.6) (1.3, 1.8) (1.06, 1.53)
Recreational Drug Use—onlyb 1.3 1.3 1.0 1.1
(1.2, 1.5) (1.1, 1.6) (0.8, 1.3) (0.9, 1.5)
Co-occurring depression and recreational drug use 2.2 1.4 2.2 1.6
(1.9, 2.6) (1.2, 1.7) (1.7, 2.7) (1.2, 2.1)
Without depression and recreational drug use(reference) 1 1 1 1
This table contains the final set of covariates retained in the multivariable Cox proportional hazard regression models for the index emergency department encounters
and hospital admissions. More information about the full model can be found in S1 Table.
aHR = Adjusted hazard ratios
CI = Confidence intervals
a There are two instruments for identifying current depression administered by clinic nurses and assistants during the participant’s regular clinical appointments. Due
to constraints on human resources and time in several HIV clinics, 61% of HIV-positive participants were administered the 10-item Kessler Psychological Distress Scale
(K10) and 39% were administrated the 20-item Centre for Epidemiologic Studies Depression Scale (CES-D20). Full details of the cohort can be found on the study
website: http://www.ohtncohortstudy.ca/
b Participants were asked whether they had used any of the following drugs for recreational or other non-medical purposes over the past six months: anabolic steroids,
amphetamines, methamphetamines, cocaine, crack/freebase, club drugs, heroin, opiates, tranquilizers, or other substances.
https://doi.org/10.1371/journal.pone.0195185.t003
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Table 4 demonstrates the multivariable associations between participant characteristics and
the three types of potentially avoidable ED encounters. Among 2,108 OCS participants with at
least one ED encounter, our multivariable analysis demonstrated that OCS participants with
current depression-only (aHR: 1.3; 95% CI: 1.1–1.5), recreational drug use-only (aHR: 1.3;
95% CI: 1.04–1.6), or co-occurring conditions (aHR: 1.3; 95% CI: 1.04–1.7) were associated
with elevated hazard of low-acuity ED encounters compared to OCS participants without cur-
rent depression and recreational drug use. Additionally, OCS participants with depression
only (aHR: 1.3; 95% CI: 1.03–1.6), recreational drug use only (aHR: 1.5; 95% CI: 1.1–1.9), or
co-occurring conditions (aHR: 1.4; 95% CI: 1.1–1.9) were associated elevated hazard of
repeated ED encounters. Furthermore, OCS participants with recreational drug use only
(aHR: 1.5; 95% CI: 1.2–2.0) were associated with elevatedhazard of ED encounters without
having sought ambulatory care 30 days prior to the index encounter.
Discussion
This is the first study to examine the relative impacts of current depression and recreational
drug use on the incidence of acute care services use among HIV-positive participants in Can-
ada. We found that HIV-positive participants with current depression-only (aHR: 1.2; 95% CI:
1.1–1.4), recreational drug use-only (aHR: 1.3; 95% CI: 1.1–1.6), or co-occurring conditions
Table 4. Adjusted hazard ratio (aHR) with 95% confidence intervals (CI) for associations between current depression and recreational drug use exposure and three
potentially avoidable emergency department (ED) encounter outcomes (N = 2,108).
Main Exposure Low-acuity ED Encounters a Repeated ED Encounters b ED encounters without seeking
ambulatory care 30 days prior
to the index encounters c
Crude HR aHR Crude HR aHR Crude HR aHR
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Depression-only d 1.2 1.2 1.3 1.3 1.03 0.97
(1.1, 1.4) (1.1, 1.5) (1.1, 1.5) (1.03, 1.6) (0.8, 1.3) (0.8, 1.3)
Recreational drug use -only e 1.3 1.3 1.4 1.5 1.5 1.5
(1.1, 1.6) (1.04, 1.6) (1.1, 1.8) (1.1, 1.9) (1.2, 1.9) (1.2, 2.0)
Co-occurring depression and recreational drug use 1.4 1.3 1.8 1.4 1.2 0.9
(1.1, 1.7) (1.04, 1.7) (1.4, 2.3) (1.1, 1.9) (0.9, 1.7) (0.7, 1.4)
Without depression and recreational drug use (reference) 1 1 1 1
This table contains the final set of covariates retained in the multivariable Cox proportional hazard regression models for the three potentially avoidable emergency
department encounter outcomes. More information about the full model can be found in S2 Table.
aHR = Adjusted hazard ratios
CI = Confidence intervals
a Low-acuity ED encounters were identified using level four or five of the five-level Canadian triage and acuity scale (1 = resuscitation, 2 = emergency, 3 = urgent,
4 = semi-urgent, 5 = non-urgent) AND a visit disposition at discharge that indicated that participants were not transferred to inpatient care.
b Repeated ED encounters were defined by discharge date of an emergency department encounter that occurred within 30 days of a previous encounter at the same or a
different facility.
c Emergency department encounters without seeking ambulatory care were defined as emergency department encounters without an ambulatory visit to a physician in
the 30 days prior to the index encounter.
d There are two instruments for identifying current depression administered by clinic nurses and assistants during the participant’s regular clinical appointments. Due
to constraints on human resources and time in several HIV clinics, 61% of HIV-positive participants were administered the 10-item Kessler Psychological Distress Scale
(K10) and 39% were administrated the 20-item Centre for Epidemiologic Studies Depression Scale (CES-D20). Full details of the cohort can be found on the study
website: http://www.ohtncohortstudy.ca/
e Participants were asked whether they had used any of the following drugs for recreational or other non-medical purposes over the past six months: anabolic steroids,
amphetamines, methamphetamines, cocaine, crack/freebase, club drugs, heroin, opiates, tranquilizers, or other substances
https://doi.org/10.1371/journal.pone.0195185.t004
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(aHR: 1.4; 95% CI: 1.2–1.7) were associated with a higher hazard of ED encounters compared
to those without these conditions. Those with current depression only (aHR: 1.2; 95% CI: 1.1–
1.5) or co-occurring current depression and recreational drug use conditions (aHR: 1.6; 95%
CI: 1.2–2.1) were associated with elevated hazard of hospital admission. More importantly,
over half of these ED encounters were potentially avoidable (low-acuity or repeated ED
encounters, or ED encounters without seeking ambulatory care). Participants with current
depression-only (1.3[1.1–1.5]; 1.3[1.03–1.6]), recreational drug use-only (1.3[1.04–1.6]; 1.5
[1.1–1.9]), or co-occurring depression and recreational drug use (1.3[1.04–1.7]; 1.4[1.06–1.9])
were associated with elevated hazard of low-acuity or repeated ED encounters respectively.
The association of current depression and/or recreational drug use with ED encounters is con-
sistent with prior studies. For example, two recent meta-analyses showed that current depres-
sion was associated with more acute care services utilization in the general population (pooled
estimate: 1.36) [30] and among patients with chronic physical conditions (pooled estimate:
1.49) [14]. Among HIV-positive participants, our results are comparable to the findings of the
two cross-sectional studies conducted in the U.S. reporting that the co-occurrence of severe
mental health disorders and injection drug use was associated with greater hospital admissions
[31] and that recreational drug use was associated with higher odds of presentation to the ED
[10]. Our cumulative incidence of ED use was also comparable to the estimate reported in a
sample of 428 HIV-positive injection drug users in British Columbia, Canada (61% vs. 63%)
[11].
Notably, our findings offer new information regarding the potentially avoidable context of
acute care use among people living with HIV and concurrent depression and recreational drug
use. There are several potential reasons for our findings. First, untreated depression and sub-
stance use problems can create barriers for people living with HIV to engage in and maintain
regular HIV care. Depression is significantly associated with a lower likelihood of achieving
optimal adherence to cART in low-, middle-, and high-income countries [32]. It is possible
that patients with unstable psychosocial situations are hesitant to initiate cART because of
their fear of drug resistance resulting from missed doses [33]. The resultant non-adherence to
cART might also increase the likelihood of ED encounters. Second, in North America, dispari-
ties in the delivery of mental health care persist: over half of people living with HIV who have
these conditions are left untreated [4–7, 34], in part because of significant fragmentation in the
integration of mental health and addiction health care [24, 35–38]. Third, the current HIV
care model focuses on treating HIV-related conditions and managing cART [39]. Bess and col-
leagues examined practices of depression treatment among 72 HIV health care providers [40].
The researchers found that only 31% of HIV providers would regularly screen their patients
for depression, and only 13% of HIV providers would follow-up with the patients after pre-
scribing antidepressants [40]. Additionally, Curran et al. (2011) found a number of key
patient-, provider-, and system-level challenges confronting HIV health care providers in pro-
viding mental health care, including: time constraints; concerns regarding drug interactions
between cART and antidepressants; difficulties with referrals to mental health specialists; over-
lap between depression and HIV symptoms; and inadequate expertise in treating depression
[41]. These factors might increase the use of potentially avoidable ED encounters.
Our findings suggest that there is an urgent need to reform the current HIV care model in
order to effectively manage multiple mental and physical co-morbidities [42, 43]. Several
recent meta-analyses have suggested that integrated or collaborative care models with treat-
ments that directly address mental health problems would improve health outcomes and qual-
ity of life in patients with cancer or diabetes [44–48]. A recent meta-analysis indicated that
improving coordination of care (e.g., multi-disciplinary team models, decision support sys-
tems, case management or self-management strategies, etc.) might reduce the use of acute care
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among patients with multiple physical and mental co-morbidities [49]. Specifically for people
living with HIV, a recent U.S. study shows that a collaborative depression care model is effec-
tive in improving quality-of-life and saving costs [50].
Several limitations in the current study need to be acknowledged. First, the screening
instruments used to identify current depression could lead to false positives. This bias is likely
to be non-differential and might drive our study associations towards null. Similarly, we relied
on self-reported data to identify recreational drug use; misclassification is possible, and we
were limited by not having information on the frequency or intensity of recreational drug use.
Second, our HIV-positive participants were recruited from HIV speciality clinics, where they
might receive more regular and better care than other people living with HIV. These patients
might be less likely to use acute care services, so our results might not generalize to the larger
HIV-positive population in Ontario. Third, we did not consider other important health sys-
tem-level and personal health choice factors that might influence acute care services use.
Future research should evaluate the potential influence of these factors and contexts.
Conclusions
We found a significant increase in ED services use and potentially avoidable ED encounters
(including low-acuity or repeated ED encounters), particularly among those with either cur-
rent depression or recreational drug use. These findings emphasize the challenges of managing
HIV and mental health and addiction co-morbidities in the current HIV care model. Future
research is needed to examine and evaluate integrated, collaborative care programs and other
strategies to improve coordination of care to effectively recognize and treat mental health and
addiction problems among people living with HIV in Ontario and Canada.
Our results support the direction of Ontario’s HIV/AIDS Strategy to 2026, which addresses
social and medical concerns associated with HIV (such as depression and substance use) and
the social drivers of health in order to enhance the overall well-being of people living with or at
risk of HIV. Our findings reinforce the importance of providing effective (and proactive) men-
tal health screening and care (as well as access and continuity of service). They also demon-
strate the need for longer term support and routine management of depression and substance
use, particularly for those individuals at highest risk, to minimize the unintended use of more
expensive acute care services in Ontario.
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